choroidal neovascularization/edema

OBJECTIVE To report the use of photodynamic therapy for treating a choroidal neovascular membrane secondary to thermal laser photocoagulation. METHODS Interventional case report. METHODS A 61-year-old man with a choroidal neovascular membrane secondary to thermal laser photocoagulation for diabetic

Vascular endothelial growth factor (VEGF) plays an important role in the pathogenesis of choroidal and retinal neovascularization. Anti-VEGF therapy changed the standard-of-care for ocular disease with neovascularisation. This article presents one promising new drug--VEGF Trap-Eye--and results of

BACKGROUND The purpose of this study was to determine the feasibility, safety and clinical effect of indocyanine green (ICG)-mediated photothrombosis (IMP) combined with intravitreal triamcinolone acetonide (IVTA) in patients with macular edema secondary to idiopathic parafoveal telangiectasis

Age-related macular degeneration, diabetic retinopathy, and retinal vein occlusions are complicated by neovascularization and macular edema. Multi-targeted kinase inhibitors that inhibit select growth factor receptor tyrosine kinases and/or components of their down-stream signaling cascades (such as

Choroidal neovascular membranes (CNVMs) developed in eight patients after photocoagulation for clinically significant diabetic macular edema (DME). The CNVMs developed in areas where Bruch's membrane was ruptured and were diagnosed 2 weeks to 5 months after treatment. Only six patients had symptoms.

OBJECTIVE Dexamethasone palmitate (DXP) is a lipophilic prodrug of dexamethasone (DXM), a potent corticosteroid used to treat a variety of ophthalmic diseases. The aim of the study was to characterize the sustained release capacity (in rabbit), efficacy (in rat and rabbit), and safety (in rabbit,

OBJECTIVE To describe a case in which a 9-year-old boy who sustained a traumatic choroidal rupture, and later developed choroidal neovascularization (CNV), was successfully treated with intravitreal bevacizumab. METHODS Comprehensive ophthalmic evaluation, including fundus photography, fluorescein

OBJECTIVE To report the effect of a single intravitreal injection of ranibizumab in a patient with choroidal neovascularization (CNV) secondary to multiple evanescent white dot syndrome (MEWDS). METHODS A 65-year-old woman with visual acuity (VA) 20/40, mild vitreous inflammation, optic disc edema,

This report describes a 19-year-old patient with the rare association of multiple evanescent white dot syndrome (MEWDS) and choroidal neovascularization (CNV). Despite the initial diagnosis of MEWDS, her vision significantly decreased. Fluorescein angiography showed dye leakage and pooling at the

OBJECTIVE To evaluate the visual and anatomic outcomes of intravitreal bevacizumab in patients with subfoveal idiopathic choroidal neovascularization (CNV). METHODS Prospective, nonrandomized, interventional case series. METHODS Forty patients with subfoveal idiopathic CNV were included in this

OBJECTIVE To report a case of laser-induced choroidal neovascularization (CNV) treated with verteporfin photodynamic therapy. METHODS Interventional case report. METHODS A patient developed CNV in the macular area of the left eye 2 years following grid laser for macular edema secondary to branch

Purpose: The purpose of this report is to describe a case of bilateral Candida chorioretinitis complicated with choroidal neovascularization (CNV) and effectively treated with combined intravitreal bevacizumab and amphotericin B. Results: An 83-year-old patient was diagnosed with